Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
NCT01232777
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Lack of funding
Conditions
Retinopathy of Prematurity
Interventions
DRUG:
Bevacizumab
Sponsor
Vision Research Foundation